Black Health Identification Program (B-HIP)

Status Recruiting

Clinical Trial Summary

Nearly 69% of African American (AA) Medicare beneficiaries have multiple chronic conditions (MCCs) such as cancer and cardiopulmonary diseases. Older age and MCCs are guideline-recommended indications for referral to early palliative care to assist with effective communication and value-solicitation surrounding treatment decision-making. Studies have shown that early palliative care participation achieves beneficial goals of care communication, quality of life (QOL), symptom burden, and mood in older adults with cancer and heart failure as well as among their family caregivers. However, older AAs with MCCs, especially those living in the Deep South, are less likely to have access to early palliative care, even though they generally experience higher symptom burden, healthcare use, and poorer communication around goals of care. This disparity in palliative care use may be, in part, to a lack of culturally-responsive care practices that effectively activate AAs with MCCs to identify their own values and priorities for end-of-life care. While efficacious communication models exist, few have been tested in culturally-diverse samples. Guided by the theory of Social Cognitive Theory and Health Behavior Model, this study's purpose is to conduct a formative evaluation of a Self-directed "My Health Priorities" Identification Program to determine cultural acceptability and feasibility of use in among AAs with MCCs in a primary care setting. The 2-phase study specific aims are to: Aim 1. (Phase 1) Conduct a single-arm formative evaluation trial of Self-directed "My Health Priorities" Identification Program to determine acceptability and feasibility with a sample of 20 AA patients with MCCs and FCGs and adapt for future efficacy testing. Aim 2. (Phase 2) To examine the ability of the dyads to complete pre- and post-test measures of perception of care, treatment burden, shared decision-making, and communication exchange. The findings from the research will directly inform a small-scale pilot grant that will assess acceptability, feasibility, and potential efficacy of a values solicitation and operationalization intervention for AAs with MCCs and caregivers.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05129709
Study type	Interventional
Source	University of Alabama at Birmingham
Contact	Tamara Nix Parker, BA
Phone	205-996-0375
Email	tmnixpar@uab.edu
Status	Recruiting
Phase	N/A
Start date	February 1, 2022
Completion date	June 30, 2024

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05419128` - Family-focused vs. Drinker-focused Smartphone Interventions to Reduce Drinking-related Consequences of COVID-19	N/A
Not yet recruiting	`NCT05558332` - Youth Nominated Support Team	N/A
Completed	`NCT05901506` - Strengthen Family Members' Understanding of Advance Care Planning With a Nurse-led, Motivational Interview	N/A
Completed	`NCT04501445` - Psychological Symptoms and Families of COVID-19 Patients	N/A
Recruiting	`NCT05500001` - Supporting Patients by Family Education in Psychotic Illness: A Prospective Cohort Study	N/A
Recruiting	`NCT06090240` - Motivational Interviewing to Enhance Advance Care Planning for Older Adults and Caregivers After Emergency Visits	N/A
Completed	`NCT03464188` - An Upstream Palliative Care Intervention for Rural and African-American Advanced Cancer Family Caregivers	N/A
Active, not recruiting	`NCT01678027` - Gastric Cancer Prevention in the Family Members by Helicobacter Pylori Eradication	Phase 3
Recruiting	`NCT06071832` - Using Structured Video Chat to Improve Relationships Between Young Children and Remote Grandparents	N/A
Recruiting	`NCT05528185` - Family Participation in CICU Rounds: RCT	N/A
Recruiting	`NCT04627662` - Using Technology to Support Care Partners for Persons With Alzheimer's Disease: Tele-STELLA	N/A
Active, not recruiting	`NCT05280691` - Family Support Intervention in Intensive Care Units	N/A
Completed	`NCT04335110` - Assessing Acceptability, Cost, and Efficacy of STELLA-Support Via Technology	N/A
Recruiting	`NCT05779813` - Genetic Frontotemporal Dementia Initiative for Neurodevelopment
Not yet recruiting	`NCT03782597` - Representations and Strategies of Families Faced With Radicalisation Process
Completed	`NCT02701361` - Mobile Mindfulness to Improve Psychological Distress After Critical Illness	N/A
Completed	`NCT04602520` - Preserving Compassionate End of Life Care in the Pandemic
Completed	`NCT04476914` - Stress Related Disorders in Family Members of COVID-19 Patients Admitted to the ICU
Recruiting	`NCT05827354` - Incidence and Factors Associated to the Development of PICS-F Among ICU Relatives: A Longitudinal Exploratory Study
Completed	`NCT03203889` - Testing Effectiveness of the Community Reinforcement Approach and Family Training (CRAFT) With American Indians	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.